THE EPIDEMIOLOGY OF HEPATITIS-C IN TURKEY

被引:30
作者
THOMAS, DL
MAHLEY, RW
BADUR, S
PALAOGLU, E
QUINN, TC
机构
[1] NIAID,IMMUNOREGULAT LAB,BALTIMORE,MD
[2] AMER BRISTOL HOSP,GLADSTONE INST,ISTANBUL,TURKEY
[3] ISTANBUL FAC MED,DEPT MICROBIOL,ISTANBUL,TURKEY
关键词
D O I
10.1007/BF01715499
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Hepatitis C virus (HCV) and hepatitis E virus (HEV) are the principal causes of non-A, non-B hepatitis worldwide, and in Turkey one-third of the cases of acute hepatitis are non-A, non-B. To explore the epidemiology of HCV in Turkey (including the association of HCV with HEV), a seroprevalence study of HCV was conducted. Sera from residents from five distinct regions of the country were tested for antibodies to HCV (anti-HCV) and HEV (anti-HEV). Anti-HCV was detected in 21 (1.5%) of 1,374 persons and was more common in residents over 54 years of age (p=0.02), with less than primary education (p=0.013), more than two children (p=0.003), and who lived in the regions of Ayvalik (p=0.046) or Trabzon (p=0.038) compared to Istanbul, Anti-HCV was marginally associated with anti-HEV, which was found in 5.9% of residents. However, this association was lost after controlling for age and education (p=0.225). HCV infection occurs in all regions of Turkey and is more common in persons who are older and of low socioeconomic status. As resources permit, efforts to reduce the transmission of HCV in Turkey (such as screening blood donations for anti-HCV) are indicated.
引用
收藏
页码:411 / 414
页数:4
相关论文
共 15 条
[1]   DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS IN PROSPECTIVELY FOLLOWED TRANSFUSION RECIPIENTS WITH ACUTE AND CHRONIC NON-A-HEPATITIS, NON-B-HEPATITIS [J].
ALTER, HJ ;
PURCELL, RH ;
SHIH, JW ;
MELPOLDER, JC ;
HOUGHTON, M ;
CHOO, QL ;
KUO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (22) :1494-1500
[2]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[3]   EVIDENCE FOR A VIRUS IN NON-A, NON-B HEPATITIS TRANSMITTED VIA THE FECAL-ORAL ROUTE [J].
BALAYAN, MS ;
ANDJAPARIDZE, AG ;
SAVINSKAYA, SS ;
KETILADZE, ES ;
BRAGINSKY, DM ;
SAVINOV, AP ;
POLESCHUK, VF .
INTERVIROLOGY, 1983, 20 (01) :23-31
[4]  
BRETTLER DB, 1990, BLOOD, V76, P254
[5]  
CAKALOGLU Y, 1992, TURK J MED BIOL RES, V3, P53
[6]   ANTIBODY TO HEPATITIS-C VIRUS AMONG CARDIAC-SURGERY PATIENTS, HOMOSEXUAL MEN, AND INTRAVENOUS-DRUG-USERS IN BALTIMORE, MARYLAND [J].
DONAHUE, JG ;
NELSON, KE ;
MUNOZ, A ;
VLAHOV, D ;
RENNIE, LL ;
TAYLOR, EL ;
SAAH, AJ ;
COHN, S ;
ODAKA, NJ ;
FARZADEGAN, H .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (10) :1206-1211
[7]   THE DECLINING RISK OF POSTTRANSFUSION HEPATITIS-C VIRUS-INFECTION [J].
DONAHUE, JG ;
MUNOZ, A ;
NESS, PM ;
BROWN, DE ;
YAWN, DH ;
MCALLISTER, HA ;
REITZ, BA ;
NELSON, KE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (06) :369-373
[8]  
ESTEBAN JI, 1989, LANCET, V2, P294
[9]   HEPATITIS-C VIRUS-ANTIBODIES AMONG RISK GROUPS IN TURKEY [J].
KOKSAL, I ;
BIBEROGLU, K ;
BIBEROGLU, S ;
KOC, F ;
AYMA, Y ;
AKER, F ;
KOKSAL, H .
INFECTION, 1991, 19 (04) :228-229
[10]   EARLY UNITED-STATES EXPERIENCE WITH ANTI-HCV KIT IN BLOOD-DONORS [J].
MENITOVE, JE ;
RICHARDS, WA ;
DESTREE, M .
LANCET, 1990, 336 (8709) :244-245